Characterizing ERBB2 Mutations in Non-Small Cell Lung Carcinoma: University Health Network Experience

被引：0

作者：

Chang, Nina ^{[1
]}

Perdrizet, Kirstin ^{[1
]}

Stockley, Tracy ^{[2
]}

Tsao, Ming ^{[3
]}

Shepherd, Frances ^{[1
]}

Wei, Cuihong ^{[1
]}

Ranich, Laura ^{[1
]}

Liu, Geoffrey ^{[1
]}

Sacher, Adrian ^{[1
]}

Bradbury, Penelope ^{[4
]}

Hwang, David ^{[5
]}

Schwock, Joerg ^{[1
]}

Ko, Hyang Mi ^{[1
]}

Boerner, Scott ^{[6
]}

Law, Jennifer ^{[4
]}

Leighl, Natasha ^{[1
]}

Pal, Prodipto ^{[7
]}

机构：

[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada

[2] Univ Hlth Network, Genome Diagnost, Toronto, ON, Canada

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[6] Univ Toronto, Univ Hlth Network, Mississauga, ON, Canada

[7] Univ Hlth Network, Scarborough, ON, Canada

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1814

引用

页数：1

共 50 条

[31] Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma
Manceau, Gilles
Letouze, Eric
Guichard, Cecile
Didelot, Audrey
Cazes, Aurelie
Corte, Helene
Fabre, Elizabeth
Pallier, Karine
Imbeaud, Sandrine
Le Pimpec-Barthes, Francoise
Zucman-Rossi, Jessica
Laurent-Puig, Pierre
Blons, Helene
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (09) : 2217 - 2221
[32] Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)
Liu, Dazhi
Keller, Rachel B.
Heilmann, Andreas M.
Allen, Justin
Oxnard, Geoffrey R.
Bazhenova, Lyudmila
Schrock, Alexa Betzig
Li, Bob T.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] ERBB2 alteration with or without co-existent EGFR mutation in metastatic non-small cell lung cancer
Singh, Vijendra
Baca, Yasmine
Kim, Seongho
Boumber, Yanis
Mamdani, Hirva
Kim, Edward S.
Sukari, Ammar
Kim, Chul
Bepler, Gerold
Liu, Stephen, V
Spira, Alexander, I
Borghai, Hossein
Nagasaka, Mikaso
CANCER RESEARCH, 2020, 80 (16)
[34] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
Shiqi Ma
Lu Zhang
Yuan Ren
Wei Dai
Tingqing Chen
Liping Luo
Juan Zeng
Kun Mi
Jinyi Lang
Bangrong Cao
Oncogene, 2021, 40 : 2596 - 2609
[35] EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features
Dundar, Bilge
Sompallae, Ramakrishna
Guseva, Natalya
Bossler, Aaron
Ma, Deqin
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1299 - 1301
[36] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
Ma, Shiqi
Zhang, Lu
Ren, Yuan
Dai, Wei
Chen, Tingqing
Luo, Liping
Zeng, Juan
Mi, Kun
Lang, Jinyi
Cao, Bangrong
ONCOGENE, 2021, 40 (14) : 2596 - 2609
[37] EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features
Dundar, Bilge
Sompallae, Ramakrishna
Guseva, Natalya
Bossler, Aaron
Ma, Deqin
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1299 - 1301
[38] ERBB2 kinase domain mutation in the lung squamous cell carcinoma
Lee, Jong Woo
Soung, Young Hwa
Kim, Su Young
Nam, Suk Woo
Park, Won Sang
Wang, Young Pil
Jo, Keon Hyun
Moon, Seok Whan
Song, Sang Yong
Lee, Jung Young
Yoo, Nam Jin
Lee, Sug Hyung
CANCER LETTERS, 2006, 237 (01) : 89 - 94
[39] Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer harboring ERBB2 exon 20 insertions and non-ERBB2 exon 20 insertions
Tu, Hai-Yan
Kai Yin
Ke, E-E
Wu, Si-Pei
Zhao, Xiaotian
Li, Yang-Si
Zheng, Mei-Mei
Liu, Si-Yang Maggie
Sun, Yue-Li
Lin, Jia-Xin
Bai, Xiao-Yan
Zhang, Yi-Chen
Qing Zhou
Yang, Jin-Ji
Zhong, Wenzhao
Wang, Bin-Chao
Zhu, Dongqin
Yang, Lingling
Ou, Qiuxiang
Wu, Yi-Long
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[40] HER-2 Mutations in Non-Small Cell Lung Cancer
Sen, Erdem
Yavas, Guler
Ata, Ozlem
MEDICAL JOURNAL OF BAKIRKOY, 2018, 14 (03) : 322 - 325

← 1 2 3 4 5 →